Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts results.
Fiche publication
Date publication
juin 2021
Journal
World journal of clinical cases
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BRONOWICKI Jean-Pierre
Tous les auteurs :
Adhoute X, Larrey E, Anty R, Chevallier P, Penaranda G, Tran A, Bronowicki JP, Raoul JL, Castellani P, Perrier H, Bayle O, Monnet O, Pol B, Bourliere M
Lien Pubmed
Résumé
Careful selection of hepatocellular carcinoma (HCC) patients prior to chemoembolization treatment is a daily reality, and is even more necessary with new available therapeutic options in HCC.
Mots clés
Barcelona Clinic Liver Cancer, Hepatocellular carcinoma, Pre-TACE-predict, Prognosis, Six-and-twelve, Transarterial chemoembolization
Référence
World J Clin Cases. 2021 Jun 26;9(18):4559-4572